Japanese drugmaker Takeda (TYO: 4502) has launched Fruzaqla (fruquintinib) in its home country. This follows the approval of ...

Akeso is awaiting approval from China's medicines regulator for a penpulimab-anlotinib combination therapy for advanced liver ...

US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief ...

Chinese biopharma CStone Pharmaceuticals has announced a strategic commercial collaboration with Pharmalink Store, a prominent pharmaceutical company based in the United Arab Emirates (UAE).

California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up ...

The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human ...

Zai Lab and Pfizer have partnered for the commercialization of Xacduro (sulbactam-durlobactam) in China, targeting carbapenem ...

Colorado, USA-based OncoVerity announced the closing of a series A extension led by existing investors, argenX and ...

Sino Biopharm has invested $20 million to acquire a 4.91% stake in LaNova Medicines, securing rights to LM-108 and other ...

AstraZeneca faces challenges in securing full FDA approval for Andexxa, its anticoagulant reversal therapy, due to safety ...

Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an ...

The US Food and Drug Administration (FDA) has granted accelerated approval of Ziihera (zanidatamab-hrii) 50mg/mL for ...